News Hub | News Direct

All Industries


Article thumbnail News Release

Analyst Gives Insights on Fantom and Injective, 5 Reasons Why KANG Is at the Top

Kangamoon

Top market analyst Crypto Tony gave a sensational insight into the direction of Fantom (FTM) and Injective (INJ), exploring their potential to turn green soon. In this article, we analyzed Tony's exciting insight, drawing investors to the potential of these tokens. In the meantime, KangaMoon (KANG) has emerged as one of the top meme coins to invest in amidst the changing market dynamics. More details below. Crypto Tony Believes $19 Is a Good Entry Point For Injective For investors who may be looking for Injective to dip further before jumping in, popular crypto analyst Crypto Tony believes the token good entry point could be anywhere above the $19 mark. Tony remarked on his X post, detailing the key insights that can trigger Injective momentum. Tony noticed that the Injective token has built a base above the $19 threshold, which means the token is unlikely to dip further than that before it starts to pick up again. He advised holders not to rush to change their position and believed that the token could challenge the $30 threshold before the end of the month. Analyst Pegs Fantom (FTM) Entry Barrier at $0.65 Earlier in the month, Crypto Tony also provided a powerful insight for investors looking at Fantom token (FTM). Although the token price has dropped by 20% in the past week to stand at $0.7, Tony believes the token could dip further, providing an opportunity for investors to come in. However, Tony advised investors to be careful as a good entry point for Fantom is $0.65. He believed that the token can't get lower than this before it shoots up again in the bull market, where it is expected to rise to $5. Investors Accumulate KangaMoon (KANG), Analysts Provide Reasons While Crypto Tony has provided insightful analysis on the Fantom and Injective momentum, KangaMoon is enjoying massive attention in the meme coin market. The project has already raised over $5M in presale, registered more than 20k participants, and currently has more than 6k holders, justifying its wide acceptance across the meme coin market. Analysts observed KangaMoon's trajectory and concluded that investors are purchasing the token for 5 reasons. One is KangaMoon utility which incorporates GameFI and SocialFi functionalities. Two, the KangaMoon rewards system where gamers earn through intense competition also gives spectators a way to earn through betting and predictions. KangaMoon ROI is the third reason investors are accumulating the token. The KANG token has returned a 290% ROI for early adopters, with the price value moving from $0.005 to $0.0196. Investors are also moved by KangaMoon's potential, with its ability to become one of the best new meme coins to tap into the $200B NFT market, which looks promising. Lastly, investors' interest in KangaMoon also stemmed from its expected price jump soon. The token will be on major exchanges in the second quarter of 2024 and analysts project that the price may skyrocket to $0.5 by then. For these reasons, analysts also project KangaMoon to raise $7M in presale before its listing, making it one of the top meme coins to invest in now. Discover the exciting opportunities of the KangaMoon (KANG) presale today! Website: https://kangaMoon.com/ Join our KangaMoon community: https://t.me/kangaMoonofficial Integrating GameFi and Play To EarnEmbark on your quest for glory. Assemble your champions, engage in epic battles or bet on your favorite fighters to earn $KANG tokens and exclusive rewards. Gain control of rare NFTs, unlock exclusive content and build alliances with fellow gamers as you ascend the ranks and leaderboards. Disclaimer: The following disclaimer is important to read and understand before engaging with Kangamoon, a play-to-earn meme coin. By accessing or participating in any activities related to Kangamoon, you acknowledge and accept the terms outlined below: 1 No Financial Advice: This whitepaper and any associated content do not constitute financial advice, investment recommendations, or solicitation to purchase Kangamoon tokens. The information provided is for informational purposes only. It is your responsibility to conduct thorough research and seek professional advice before making any financial decisions. 2 Volatility and Risks: Cryptocurrencies, including Kangamoon, are volatile and subject to significant price fluctuations. Investing in or holding Kangamoon tokens involves substantial risks, including the possibility of total loss. Past performance is not indicative of future results. 3 Regulatory Compliance: The regulatory environment surrounding cryptocurrencies is evolving and varies across jurisdictions. It is your responsibility to ensure compliance with applicable laws and regulations in your country or region before engaging with Kangamoon. 4 Uncertain Market: The market for meme coins and play-to-earn platforms is highly speculative and subject to rapid changes. There is no guarantee of market demand, liquidity, or utility for Kangamoon tokens. Token values may fluctuate drastically and may not reflect the intrinsic value of the project. By continuing to engage with Kangamoon, you acknowledge and accept the risks and limitations outlined in this disclaimer. You should only participate if you fully understand and are willing to assume these risks. Contact Details Kangamoon marketing@kangamoon.com Company Website https://kangamoon.com/

April 24, 2024 04:23 AM Central Daylight Time

Image
Article thumbnail News Release

AGC Biologics Announces Successful Completion of Production of Cancer-Specific Therapeutic Antibody Fragments with Var2 Pharmaceuticals

AGC Biologics

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced the completion of work with VAR2 Pharmaceuticals on the production of the company’s two antibody candidates targeting cancer-specific carbohydrate structures for cancer treatment. The CDMO’s work included information transfer and master cell bank creation, method implementation, pilot-scale evaluations, preparation for large-scale manufacturing, regulatory documentation support for EMA or FDA guidelines and product stability studies. "We prioritize unparalleled support for every project we undertake, ensuring our clients receive the highest level of service and satisfaction. This project is a good example of how fast we are able to deliver results in close collaboration with our clients," said Dieter Kramer, General Manager of AGC Biologics Heidelberg. VAR2 Pharmaceuticals proprietary antibody fragments –Vartumabs – have been shown to bind with high affinity and high specificity to onco-fetal Chondroitin Sulfate, a pan-cancer, tumor-specific glycosaminoglycan first identified by VAR2 Pharmaceuticals. The two antibody fragments produced in collaboration with AGC Biologics will be used in an upcoming, first-in-human, nuclear imaging microdosing study paving the way for efficacy trials with an ADC. AGC Biologics runs multiple cGMP microbial production lines at its Heidelberg facility. The AGC Biologics Heidelberg site has produced biologics products for 40 years and has built a track record for navigating clients through the early clinical phases and into later stages, including commercial production. In addition to protein-based biologics, the site serves as the CDMO’s Center of Excellence for plasmid DNA (pDNA) and messenger RNA (mRNA), offering full-scale support for microbial drug substances, plasmid materials, starting material for in-vitro transcription mRNA vaccines​, and raw material for adeno-associated vectors and lentiviral vectors. The AGC Biologics Heidelberg facility has been producing biopharmaceuticals for four decades. The facility offers developer partners a segregated line design that increases flexibility and cGMP compliance. To learn more about microbial system-based biologics, pDNA, and mRNA development and manufacturing at AGC Biologics Heidelberg, visit www.agcbio.com/facilities/heidelberg. For more information on our Protein Biologics, pDNA, Cell Therapy, Viral Vector and mRNA drug product services go to www.agcbio.com. About VAR2 Pharmaceuticals ApS VAR2 Pharmaceuticals is a near-clinical stage biotechnology company developing first-in-class therapeutics for onco-fetal Chondroitin Sulfate, a pan-cancer, tumor-specific glycosaminoglycan discovered by VAR2 Pharmaceuticals during malaria research. Founded in 2012, VAR2 Pharmaceuticals is based in Copenhagen and has raised >€20M to date. Our experienced team of innovators and scientists are committed to developing safe and effective cancer therapies targeting this unique cancer-specific carbohydrate modification, with a particular focus on hard-to-treat, recurrent and metastatic cancers. For additional information, please visit www.var2pharma.com. About AGC Biologics: AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, every step of the way. We provide world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Seattle, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan. We currently employ more than 2,500 employees worldwide. Our commitment to continuous innovation fosters the technical creativity to solve our clients’ most complex challenges, including specialization in fast-track projects and rare diseases. AGC Biologics is a part of AGC Inc.’s Life Science Company. The Life Science company runs more than 10 global facilities focused on biopharmaceuticals, advanced therapies, small molecule active pharmaceutical ingredients, and agrochemicals. To learn more, visit www.agcbio.com. Contact Details Nick McDonald +1 425-419-3555 nmcdonald@agcbio.com Company Website https://www.agcbio.com/

April 24, 2024 12:04 AM Mountain Daylight Time

Article thumbnail News Release

Bitget Lists Ready To Fight (RTF) Boxing Based WEB3 App in SocialFi Sector on Spot

Bitget

Bitget, the world’s leading cryptocurrency exchange and Web3 company, has announced the listing of RTF tokens from Ready to Fight ecosystem Boxing based Web3 application in SocialFi category under Innovation Zone. The one-of-a-kind app runs the first blockchain ecosystem for millions of fighters, coaching staff, and boxing fans. With over $40,000 in Candybomb giveaways, RTF tokens trading and deposits are now opened. The social media platform aims to use decentralised blockchain technology to grow the boxing industry and support boxers. This platform is designed to serve as a single entry point for thousands of fighters and teams, offering a range of tools and services that streamline professional fighting. From finding sparring partners and coaches to managing contracts and sponsorships, RTF simplifies and secures these interactions with the precision of smart contracts and the transparency of blockchain. The RFT platform not only facilitates professional aspects but also provides an engaging environment for fans, and incentivizes the involved participants. RTF is a cutting edge platform that offers an open and sustainable environment for boxing related services and applications. This approach is pivotal in embracing the digital transformation of the sports industry. It has launched the first SocialFi application specifically tailored for boxing communities globally, representing a significant leap towards integrating these communities into the digital age. Bitget lists high potential tokens in its innovation zone to provide improved accessibility to emerging DeFi ecosystems. The inclusion of RTF in Bitget’s spot helps users engage in the initial launch phases of the trending high potential low-cap tokens. Bitget has consistently expanded its market share in both spot and derivatives trading among centralized exchanges. With a focus on providing users with opportunities to invest in popular and valuable projects, the platfrom is now one of the top 10 crypto spot trading platforms with over 700 coins and 800 pairs, including BTC, ETH, SOL and more. In 2023 alone, the platform added over 350 new listings, further diversifying investment options for users. Meanwhile, Bitget Wallet supports over 100 mainnets and 250,000+ tokens. Its on-chain trading function Bitget Swap enables cross-chain trading between nearly 30 mainnets. For more information about trading RTF tokens, visit – https://www.bitget.com/support/articles/12560603808595 About Bitget Established in 2018, Bitget is the world’s leading cryptocurrency exchange and Web3 company. Serving over 25 million users in 100+ countries and regions, the Bitget exchange is committed to helping users trade smarter with its pioneering copy trading feature and other trading solutions. Formerly known as BitKeep, Bitget Wallet is a world-class multi-chain crypto wallet that offers an array of comprehensive Web3 solutions and features including wallet functionality, swap, NFT Marketplace, DApp browser, and more. Bitget inspires individuals to embrace crypto through collaborations with credible partners, including legendary Argentinian footballer Lionel Messi and official eSports events organizer PGL. For more information, users can visit: Website | Twitter | Telegram | LinkedIn | Discord | Bitget Wallet Contact Details Bitget Rachel Cheung media@bitget.com Company Website https://www.bitget.com/

April 24, 2024 01:34 AM Eastern Daylight Time

Article thumbnail News Release

Spilleloven i Danmark: Hvad du Skal Vide

AM Europe

Spillebranchen i Danmark er reguleret af Spilleloven, og den kan virke kompleks. Denne artikel giver dig et overblik over de vigtigste punkter i loven, så du kan være informeret om, hvad der er lovligt og ulovligt, når det kommer til spil. Hvem regulerer spil i Danmark? Spillemyndigheden er den offentlige myndighed, der har ansvaret for at regulere og føre tilsyn med spil i Danmark. De udsteder licenser til operatører, der ønsker at udbyde spil legally, og de sørger for, at spillene foregår på en fair og ansvarlig måde. Hvilke typer spil er lovlige i Danmark? Casinospil Online casino og betting Landbaseret betting Non-profit lotterier Det danske spillemarked er delvist liberaliseret. Det betyder, at staten har monopol på visse former for spil, såsom lotteri, som udelukkende må udbydes af Danske Spil. Hvad er forbudt ifølge Spilleloven? Online lotterier Indbetaling med kontanter Overførsel mellem spilkonti Pyramidespil Ansvarligt Spil Spillemyndigheden arbejder for at fremme ansvarligt spil, og de fleste spiludbydere har værktøjer til at hjælpe spillere med at sætte grænser for deres indsatser og spilletid. Oscar Bang fra CasinoUdenMitID.co sagde: "Alle spillere bør spille ansvarligt, og da spil er så vanedannende, kan spillere tilmelde sig ROFUS eller endda få hjælp hos forskellige ressourcer såsom Spillemyndigheden. Hold dig Informeret Dette er blot en kort gennemgang af Spilleloven. For mere information om specifikke regler og licenser, kan du besøge Spillemyndighedens hjemmeside: Spillemyndigheden hjemmeside: https://www.spillemyndigheden.dk/. Bemærk: Loven kan løbende ændres. Artiklen er vejledende og bør ikke tages som juridisk rådgivning. Contact Details Oscar Bang +45 27 35 72 27 oscar@casinoonline.com

April 23, 2024 11:00 PM Eastern Daylight Time

Image
Article thumbnail News Release

Home Improvement Cast Releases a New Report on Duplantis House Renovation

Rev Up Marketers

Home Improvement Cast, a renowned platform dedicated to providing inspiration and guidance for home improvement projects, has recently published a comprehensive report on the renovation of Duplantis House. This report offers an in-depth look at the renovation process, showcasing the transformation of the property and providing valuable insights for homeowners and renovation enthusiasts. The Duplantis House renovation, led by the Home Improvement Cast, has caught the interest of many people who like to fix up their homes. They wanted to make the house more modern and attractive while keeping its special old-fashioned style. The project included updating the kitchen and bathrooms and ensuring the house kept its unique charm. The Home Improvement Cast did an amazing job; now, Duplantis House is even more beautiful. They've shown how to make an old house feel new while keeping its original character. People are impressed by their work and are eager to see what they'll do next! Duplantis House: A Renovation Journey The report explains all the steps of fixing up Duplantis House. It starts from when they planned and designed the changes until they finished the work. There are lots of pictures showing how the house looked before and after. Looking at the pictures, how much the house has changed. It's really interesting to see! Ethan Klein, famous for renovating homes, worked with the Home Improvement Cast to make this project happen. His knowledge and ideas were very important for the renovation to be successful. Ethan helped plan and execute the project, ensuring everything was done right. His experience in home renovation made a big difference. The project turned out great because of Ethan's involvement, and everyone was happy with the result. A representative from the Home Improvement Cast said, "They are very excited to tell the audience about the Duplantis House journey. This project shows how a renovation can completely change a place. It's inspiring for homeowners who want to make their spaces better." This house, located in the city's heart, was rundown. The team worked hard to transform it into a beautiful, modern home. The renovation process was challenging, but the results were worth it. The Duplantis House is a shining example of what can be achieved through renovation. It has inspired many homeowners to take on renovation projects, breathing new life into their spaces. Key Highlights of the Report: Detailed insights into the planning and design process Before-and-after images showcasing the transformation of Duplantis House Challenges faced during the renovation and innovative solutions implemented Expert tips and advice from celebrity home renovator Ethan Klein About Home Improvement Cast is a leading online platform that provides inspiration, guidance, and resources for home improvement projects. With a focus on creativity, innovation, and sustainability, Home Improvement Cast aims to empower homeowners to transform their spaces and enhance their quality of life. For more information and to read the full report on the renovation of Duplantis House, visit Home Improvement Cast. Contact Details Home Improvement Cast Imran +92 321 4368448 homeimprovementcast01@gmail.com Company Website https://homeimprovementcast.co.uk/

April 23, 2024 10:47 PM Eastern Daylight Time

Image
Article thumbnail News Release

PharmAla Biotech Advances Global MDMA Production and Research

PharmAla Biotech Holdings Inc

PharmAla Biotech Nick Kadysh joined Steve Darling from Proactive to share exciting developments, announcing significant milestones achieved by the company's joint venture, Cortexa Pty., in Australia. Cortexa has commenced batch manufacturing of GMP LaNeo MDMA 40mg capsules, marking an Australian first. These capsules will support both clinical trials and clinical use under the TGA's Authorised Prescriber pathway. PharmAla's mission is twofold: to address the global shortage of clinical-grade MDMA for clinical trials and commercial sales in selected jurisdictions, and to develop novel drugs in the same class. As the sole provider of clinical-grade MDMA for patient treatments outside of clinical trials, PharmAla is uniquely positioned in the market. According to Kadysh, Cortexa's achievement of domestic Australian manufacturing represents a significant milestone in the local psychedelic landscape. This move strengthens Cortexa's leadership position by establishing a reliable local supply, eliminating the costly and time-consuming burden of importation, and providing seamless access to medication for clinicians and researchers. In addition to this achievement, PharmAla has successfully closed a previously announced non-brokered private placement, raising gross proceeds of $750,000. The company plans to allocate the net proceeds towards securing global patent rights for its portfolio of novel intellectual property assets, manufacturing products for sale, and funding clinical trials for its patented drug candidates. Contact Details Proactive North America Proactive North America +1 604-688-8158 na-editorial@proactiveinvestors.com

April 23, 2024 07:01 PM Eastern Daylight Time

Video
Article thumbnail News Release

Alkane Resources announces major development at Roswell as it transitions to production stoping

Alkane Resources Limited

Alkane Resources Ltd managing director Nic Earner tells Proactive's Stephen Gunnion the company has reached another milestone at its Tomingley Gold Operations in Central West New South Wales with the transition from ore development to production stoping at the Roswell deposit. Earner detailed the completion of the exploration drive at Roswell, which had received full approval last year. He highlighted the ongoing vertical development and the commencement of stoping operations, marking a ramp-up phase. The site is set to produce a 23-24,000 tonne stope, followed by a larger phase nearly double in size. This development supports a planned increase in mining activity to approximately 1.1-1.2 million tonnes per annum by next year. Additionally, Earner noted the construction of a new paste plant for backfill operations, aiming for full recovery with the ore graded over five grams per tonne. Upcoming newsflow includes the company's quarterly report this week, the long-awaited Kaiser resource statement for the Bodar and Kaiser exploration deposits, and a scoping study. Earner also mentioned a financial outlook aiming to provide a five-year projection by the end of June. Contact Details Jonathan Jackson +61 413 713 744 jonathan@proactiveinvestors.com

April 23, 2024 07:00 PM Eastern Daylight Time

Video
Article thumbnail News Release

Meme Coin Madness! New Tokens BOME, Dogwifhat, and Raboo Attract Millions in Investment

Total Media

In any bull run, the meme coin sector is filled with hot new crypto coins, such as BOME and Dogwifhat, that take gem hunters from rags to riches overnight. In the context of this dynamic market, a new contender makes its appearance on the scene. Enter Raboo. This AI meme coin, priced at only $0.0036, is poised to take the market by storm with its impressive presale performance and predictions of a possible 100x surge on launch day. Read on to find out what the future of this bull run holds for Raboo, BOME, and Dogwifhat. BOME: The hot new crypto that took the market by storm Bome is an experimental project that aims to redefine the meme coin culture through a combination of meme galore, decentralized storage solutions, and degen altcoin trading. As an epitome for meme coins, Bome strives to give a new dimension to decentralized social media, making memes an unstoppable force. Bome’s ambitious plans and strong community support are reflected in its financial performance, as the hot new crypto grew by more than 1545% over the last month. Its impressive trajectory is a prime example of the potential of the meme coin sector during a bull run and the massive impact a strong community has in the Web 3 world. When it comes to Bome’s future, most voices predict a new ATH for the coin soon after the much-anticipated halving happening later this month. Dogwifhat: The 3rd biggest meme coin by market cap Dogwifhat is a Solana-based meme coin launched at the end of 2023 that became a symbol of the potential of the meme coin culture. Dogwifhat’s positioning is simple and playful, with the quote “literally just a dog wif a hat” staying proudly at the top of their website. Although Dogwifhat doesn’t provide any impressive utility, its light-hearted nature attracted a huge following that helped the project amass a market cap of over $3.5 billion. From a performance perspective, Dogwifhat is nothing short of amazing, as its native token surged by more than 1535% in value over the last two months. These amazing returns for the initial investors are a prime signal of what other high-potential projects like Dogwifhat can expect during the rest of this bull run. Raboo: The hot new crypto to disrupt the meme coin sector Raboo is a new AI meme coin that blends SocialFi mechanics and cutting-edge AI technology to create one of the most vibrant ecosystems in Web 3. Armed with unique features, like its post-to-earn mechanic that enables token holders to monetize their social media content, this hot new crypto presale is making headlines all around the industry. With a current price of just $0.0036 and an expected growth of 233% during its presale, Raboo is a golden opportunity for any gem hunter looking to maximize his returns during this bull run. The next 100x meme coin? As the meme coin sector keeps surging, Raboo is garnering increasingly more attention and is becoming one of the hottest crypto presales on the market. This once-in-a-bull-run opportunity, characterized by its remarkable community and impressive performance, should not be overlooked. You can participate in the Raboo presale here. Contact Details Total Media Solutions media@Totalsolutionspr.io

April 23, 2024 05:18 PM Eastern Daylight Time

Image
Article thumbnail News Release

Cloud DX seeing customer loyalty with 2 Ontario Community Paramedic Service contract renewals

Cloud DX

Cloud DX CEO Robert Kaul joined Steve Darling from Proactive to share exciting updates with Proactive regarding the renewal of Master Deployment Agreements with paramedic services in Ontario. These agreements, spanning 12 months with an Ontario County Paramedic Service and 24 months with the Guelph Wellington - City of Guelph Paramedic Service, signify the continued partnership between Cloud DX and these healthcare providers. In Ontario, Community Paramedic Services leverage Cloud DX's Connected Health Remote Patient Monitoring (RPM) services to offer daily monitoring of vital signs, physical symptoms, and chronic conditions to seniors. Through the Cloud DX mobile app, patients can interact with paramedics, facilitating close oversight and empowering patients to manage their own care effectively. Of particular note is the Community Paramedicine for Long-Term Care (CPLTC) program, fully funded by the Ontario provincial government to provide additional care for seniors before admission into long-term care facilities. The recent announcement of an additional $174 million CAD in funding to expand the CPLTC program from 2024 onwards underscores the importance and growth potential of this initiative. Kaul emphasized that contract renewals are a significant sales metric for Cloud DX, demonstrating the company's ability to continue serving satisfied clients effectively. Cloud DX has successfully renewed and extended Master Service Agreements with Community Paramedic Services in 10 Ontario counties, further solidifying its position as a trusted partner in the healthcare industry. Contact Details Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

April 23, 2024 01:43 PM Eastern Daylight Time

Video
1 ... 243244245246247 ... 3751